memantine has been researched along with Astrocytosis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with memantine resulted in significant improvement (p < 0." | 1.72 | Memantine associated with ventricular-subcutaneous shunt promotes behavioral improvement, reduces reactive astrogliosis and cell death in juvenile hydrocephalic rats. ( Almeida, TAL; Beggiora, PDS; da Silva, SC; Lopes, LDS; Machado, HR; Rodrigues, KP; Sampaio, GB; Silva, GAPM, 2022) |
| "Memantine is an FDA-approved drug for treating Alzheimer's disease, and also was shown to be neuroprotective in rodents following a single, moderate to severe TBI." | 1.46 | Memantine Reduced Cell Death, Astrogliosis, and Functional Deficits in an in vitro Model of Repetitive Mild Traumatic Brain Injury. ( Effgen, GB; Morrison, B, 2017) |
| "Treatment with memantine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist significantly attenuated Abeta(25-35)-induced changes of neuropeptides, their metabolizing enzymes, glial marker proteins, and activation of iNOS." | 1.35 | Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions. ( Ahmed, MM; Arif, M; Chikuma, T; Kato, T; Nakazato, M; Smith, MA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beggiora, PDS | 1 |
| da Silva, SC | 1 |
| Rodrigues, KP | 1 |
| Almeida, TAL | 1 |
| Sampaio, GB | 1 |
| Silva, GAPM | 1 |
| Machado, HR | 1 |
| Lopes, LDS | 1 |
| Al-Hazmi, MA | 1 |
| Rawi, SM | 1 |
| Arafa, NM | 1 |
| Wagas, A | 1 |
| Montasser, AO | 1 |
| Effgen, GB | 1 |
| Morrison, B | 1 |
| Arif, M | 1 |
| Chikuma, T | 1 |
| Ahmed, MM | 1 |
| Nakazato, M | 1 |
| Smith, MA | 1 |
| Kato, T | 1 |
| Wenk, GL | 2 |
| McGann-Gramling, K | 1 |
| Hauss-Wegrzyniak, B | 1 |
| Rosi, S | 1 |
| Vazdarjanova, A | 1 |
| Ramirez-Amaya, V | 1 |
| Worley, PF | 1 |
| Barnes, CA | 1 |
6 other studies available for memantine and Astrocytosis
| Article | Year |
|---|---|
Memantine associated with ventricular-subcutaneous shunt promotes behavioral improvement, reduces reactive astrogliosis and cell death in juvenile hydrocephalic rats.
Topics: Animals; Cell Death; Gliosis; Hydrocephalus; Male; Memantine; Rats; Rats, Wistar; Receptors, N-Methy | 2022 |
The potent effects of ginseng root extract and memantine on cognitive dysfunction in male albino rats.
Topics: Acetylcholinesterase; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric | 2015 |
Memantine Reduced Cell Death, Astrogliosis, and Functional Deficits in an in vitro Model of Repetitive Mild Traumatic Brain Injury.
Topics: Animals; Brain Concussion; Cell Death; Gliosis; Hippocampus; Memantine; Models, Neurological; Neurop | 2017 |
Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Brain; CD11 Antigens; Disease Models, | 2009 |
The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Choline O-Acetyltransfera | 2004 |
Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat.
Topics: Animals; Behavior, Animal; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship | 2006 |